Abstract
Summary
Results from bone biopsy and high-resolution peripheral quantitative computed tomography (HR-pQCT) were compared in 31 CKD patients. There was an agreement mainly for cortical compartment that may represent a perspective on the fracture risk assessment. HR-pQCT also provided some clues on the turnover status, which warrants further studies.
Introduction
Chronic kidney disease (CKD) patients are at high risk of bone disease. Although bone biopsy is considered the best method to evaluate bone disease, it is expensive and not always available. Here we have compared, for the first time, data obtained from bone biopsy and HR-pQCT in a sample of CKD patients on dialysis.
Methods
HR-pQCT and dual-energy X-ray absorptiometry (DXA) were performed in 31 CKD patients (30 on dialysis). Biopsies were analyzed by quantitative histomorphometry, and classified according to TMV.
Results
We have found an inverse correlation between radius cortical density measured by HR-pQCT, with serum, as well as histomorphometric bone remodeling markers. Trabecular density and BV/TV measured through HR-pQCT in the distal radius correlated with trabecular and mineralized trabecular bone volume. Trabecular number, separation, and thickness obtained from HR-pQCT and from bone biopsy correlated with each other. Patients with cortical porosity on bone histomorphometry presented lower cortical density at the distal radius. Cortical density at radius was higher while bone alkaline phosphatase was lower in patients with low turnover. Combined, these parameters could identify the turnover status better than individually.
Conclusions
There was an agreement between HR-pQCT and bone biopsy parameters, particularly in cortical compartment, which may point to a new perspective on the fracture risk assessment for CKD patients. Besides classical bone resorption markers, HR-pQCT provided some clues on the turnover status by measurements of cortical density at radius, although the significance of this finding warrants further studies.
Similar content being viewed by others
References
Kidney Disease: Improving Global Outcomes CKDMBDWG (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl S1-130
Fusaro M, Gallieni M, Jamal SA (2014) Fractures in chronic kidney disease: neglected, common, and associated with sickness and death. Kidney Int 85:20–22
Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166–173
Wakasugi M, Kazama JJ, Narita I (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 86:649
Goldenstein PT, Jamal SA, Moyses RM (2015) Fractures in chronic kidney disease: pursuing the best screening and management. Curr Opin Nephrol Hypertens 24:317–323
Jamal SA, West SL, Miller PD (2012) Fracture risk assessment in patients with chronic kidney disease. Osteoporos Int 23:1191–1198
Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590
Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study. Nephrol Dial Transplant 27:345–351
Jamal S, Cheung AM, West S, Lok C (2012) Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int 23:2805–2813
Jamal SA, Nickolas TL (2015) Bone imaging and fracture risk assessment in kidney disease. Curr Osteoporos Rep 13:166–172
West SL, Lok CE, Langsetmo L, Cheung AM, Szabo E, Pearce D, Fusaro M, Wald R, Weinstein J, Jamal SA (2015) Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res 30:913–919
Yenchek RH, Ix JH, Shlipak MG et al (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7:1130–1136
Negri AL, Del Valle EE, Zanchetta MB, Nobaru M, Silveira F, Puddu M, Barone R, Bogado CE, Zanchetta JR (2012) Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients. Osteoporos Int 23:2543–2550
Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, McMahon DJ, Leonard MB, Shane E (2010) Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol 21:1371–1380
Cohen A, Dempster DW, Muller R et al (2010) Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int 21:263–273
Pereira RC, Bischoff DS, Yamaguchi D, Salusky IB, Wesseling-Perry K (2015) Micro-CT in the assessment of pediatric renal osteodystrophy by bone histomorphometry. Clin J Am Soc Nephrol
Tamminen IS, Isaksson H, Aula AS, Honkanen E, Jurvelin JS, Kroger H (2011) Reproducibility and agreement of micro-CT and histomorphometry in human trabecular bone with different metabolic status. J Bone Miner Metab 29:442–448
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610
Dos Reis LM, Batalha JR, Munoz DR, Borelli A, Correa PH, Carvalho AB, Jorgetti V (2007) Brazilian normal static bone histomorphometry: effects of age, sex, and race. J Bone Miner Metab 25:400–406
Vedi S, Compston JE, Webb A, Tighe JR (1983) Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Relat Res 5:69–74
Moe S, Drueke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953
Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26:1368–1376
Pasoto SG, Augusto KL, Alvarenga JC, Takayama L, Oliveira RM, Bonfa E, Pereira RM (2016) Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary Sjogren's syndrome. Rheumatology (Oxford) 55:2200–2211
Cejka D, Patsch JM, Weber M, Diarra D, Riegersperger M, Kikic Z, Krestan C, Schueller-Weidekamm C, Kainberger F, Haas M (2011) Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. Clin J Am Soc Nephrol 6:2264–2271
Nickolas TL, Stein EM, Dworakowski E et al (2013) Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res 28:1811–1820
Amstrup AK, Jakobsen NF, Moser E, Sikjaer T, Mosekilde L, Rejnmark L (2015) Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women. J Bone Miner Metab
Jones G (2015) Interpreting vitamin D assay results: proceed with caution. Clin J Am Soc Nephrol 10:331–334
Cooper D, Turinsky A, Sensen C, Hallgrimsson B (2007) Effect of voxel size on 3D micro-CT analysis of cortical bone porosity. Calcif Tissue Int 80:211–219
Acknowledgements
Operating grant 2011/22962-3 provided by Fundação de Amparo à Pesquisa do Estado de São Paulo—FAPESP, supported this work. This work was presented in part at ASN meeting, 2014, Philadelphia, USA. E. David-Neto, R. Moysés and V. Jorgetti were supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Drs. Rosa Moysés and Vanda Jorgetti have received honoraria for lectures and are on the speaker’s bureau for Amgen. Igor Marques, Maria Júlia Araújo, Fabiana Graciolli, Luciene dos Reis, Rosa Pereira, Melani Custódio, Rosilene Elias, and Elias David-Neto declared they have no conflict.
Electronic supplementary material
Supplementary Table 1
(DOCX 17 kb)
Supplementary Table 2
(DOCX 18 kb)
Supplementary Table 3
(DOCX 18 kb)
Supplementary Figure 1
(DOCX 76 kb)
Supplementary Figure 2
(DOCX 63 kb)
Rights and permissions
About this article
Cite this article
Marques, I.D.B., Araújo, M.J.C.L.N., Graciolli, F.G. et al. Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int 28, 1675–1683 (2017). https://doi.org/10.1007/s00198-017-3956-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-017-3956-9